JuveXO is launching JuveXO Aesthetics, a new physician-dispensed exosome skincare line that includes JuveXO Skin, JuveXO Hair, and JuveXO Lyo.
Derived from umbilical lining stem cells (ULSCs), a form of mesenchymal stem cell (MSC), JuveXO is produced through ExoCM, a proprietary, patent-pending technology that enables control of the factors released by ULSCs.
JuveXO naturally secretes types I and III collagen, biotin, gluthathione, chondroitin sulfate, growth factors, and high-molecular-weight hyaluronic acid.
Previously, JuveXO offered JuveXO Pro, a multi-dose vial designed for professional aesthetic skincare treatments that contains 50 billion exosomes per mL and JuveXO Pro H for scalp and hair restoration with 50 billion exosomes per mL.
“With JuveXO Aesthetics, we’re bringing a decade of exosome research into the hands of skincare and hair professionals. Our exosomes are not only verified but naturally secrete the key actives other brands synthetically add—like collagen, growth factors, and hyaluronic acid. This is specifically designed for improving skin health in cosmetic applications, and it reflects our commitment to science-backed performance in every vial,” says Rafael Gonzalez, PhD, Chief Science and Development Officer for Congela Biocosmetics, in a news release.
JuveXO Aesthetics line features an optimized exosome concentration and pricing model. The products are powered by the ExoCM formula.
Product Lineup
The new JuveXO Aesthetics line includes:
- JuveXO Skin, a multi-dose vial designed for professional aesthetic skincare treatments that comprises 50 billion exosomes per mL. JuveXO Skin was created for professional use following microneedling, laser, dermabrasion, or other advanced aesthetic treatments.
- JuveXO Hair for scalp and hair restoration applications has 50 billion exosomes per mL and supports post-procedural scalp and follicle protocols, including microneedling and transdermal energy delivery (TED).
- JuveXO Lyo, a lyophilized formula with 25 billion exosomes per vial, can be reconstituted for up to five patients. JuveXO Lyo gives practitioners flexible dosing options based on treatment type and patient needs.
